This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: Creative Biosciences (Guangzhou) Co., Ltd.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Rongsong Zhao: Innovator in Tumor Detection Technologies
Introduction
Rongsong Zhao is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of biology, particularly in the detection and diagnosis of colorectal cancer. With a total of 2 patents, Zhao's work focuses on innovative methods for identifying tumor markers and methylation levels in genetic material.
Latest Patents
Zhao's latest patents include a tumor marker and a methylation detection reagent, along with a kit and its applications. This invention relates to the technical field of biology and provides a method for distinguishing colorectal cancer specimens from normal fecal samples by detecting the methylation level of the COL4A1 gene promoter region. Additionally, he has developed a molecular detection/diagnosis reagent for tumors that utilizes excrement as a detection sample. This reagent includes an SDC2 gene methylation detection component, which has shown a sensitivity of 87 percent and a specificity of up to 98 percent or higher compared to tissue samples.
Career Highlights
Throughout his career, Rongsong Zhao has worked with Creative Biosciences (Guangzhou) Co., Ltd. and Creative Biosciences Co., Ltd. His innovative approaches have positioned him as a key figure in the development of diagnostic tools for cancer detection.
Collaborations
Zhao has collaborated with notable professionals in his field, including Hongzhi Zou and Feng Niu. Their combined expertise has contributed to advancements in cancer detection technologies.
Conclusion
Rongsong Zhao's contributions to the field of tumor detection highlight his innovative spirit and dedication to improving cancer diagnosis. His work continues to pave the way for advancements in medical technology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile